Belenos
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.belenosbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Belenos
Belenos Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Belenos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Belenos is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Belenos has new funding data
Product Launch: Get notified when Belenos launches new products
Check if Belenos has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Belenos recently announced quarterly report
Click to see if Belenos had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Belenos
Website visits: Recent activity has been detected on your website
Belenos, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Belenos is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Belenos is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Belenos.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Belenos
Belenos Biosciences is a clinical-stage biotechnology company committed to transforming the treatment of chronic inflammatory diseases into outcomes where clinical remission becomes standard. The company focuses on developing long-acting, dual-targeted bispecific antibody therapeutics aimed at validated disease pathwaysbringing together deep immuno... Read More
